Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Intellia Therapeutics, Inc. Financials Banner

Intellia Therapeutics, Inc. Financials

NTLA Stock Analysis

Page title

Section title

NTLA Income Statement Key Metrics

  • Revenue(TTM)43.09 M
  • Gross Profit(TTM)35.51 M
  • EBITDA(TTM)-527.52 M
  • Net Income(TTM)-522.28 M
  • EPS Diluted(TTM)-5.44

Decode NTLA's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

NTLA earnings and revenue history

Gross Profit Margin vs Peers

Profit margin ratio of NTLA (0.753) is higher than the average of its peers (0.610).

Net Profit Margin vs Peers

Net profit margin ratio of NTLA (-13.265) is lower than the average of its peers (-2.842).

NTLA Return on Equity

See how efficiently NTLA generates profit for it's shareholders.

-45.82%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of NTLA (-0.458) is higher than the average of its peers (-0.479).

Return on Equity Growth

NTLA's Return on Equity has shown poor growth over the past 10 years, increasing by only -13.22%.

NTLA Revenue Growth

See how NTLA has grown it's revenue over the past 10 years.


Revenue Growth

NTLA's revenue has grown significantly over the past 10 years, increasing by over 0%.

NTLA FY, 2023 Revenue Breakdown

See how NTLA converts it's revenue into profit.

NTLA Balance Sheet Health

NTLA Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

NTLA financial position analysis

Short Term Liabilities

NTLA's short term assets($998M) can safely cover it's short term liabilities($115M).

Long Term Liabilities

NTLA's short term assets($998M) can safely cover it's long term liabilities($136M).

NTLA Debt to Equity